Aberrant protein activity rewires lymphoma cells to survive BTK inhibitors, offering target for treatment resistance. A protein that can dial down oxidative stress in cells helps some cancers resist treatment with a widely used class of drugs called BTK inhibitors, according to a study led by investigators at Weill Cornell Medicine.
A apuração publicada por medicalxpress.com vira base para uma leitura editorial direta e contextualizada.
Trechos de apoio da pauta: A protein that can dial down oxidative stress in cells helps some cancers resist treatment with a widely used class of drugs called BTK inhibitors, according to a study led by investigators at Weill Cornell Medicine. The discovery points to a possible solution to the problem of BTK inhibitor treatment resistance.
- Ponto de atenção: aberrant.
- Ponto de atenção: protein.
- Ponto de atenção: activity.
Em resumo, a leitura editorial acompanha o impacto do tema no nicho Saúde.
